Skip to main content
. 2020 Nov 4;8(1):e907. doi: 10.1212/NXI.0000000000000907

Figure 1. Beta diversity between AQP4+ and healthy controls.

Figure 1

(A) 3D principal component analysis (PCoA) of weighted UniFrac distances of 16S rRNA genes showing significant beta diversity between AQP4+ patients (green) and healthy controls (red). (B) Results of pairwise PERMANOVA analysis showing a significant difference in beta diversity (p < 0.001, pairwise PERMANOVA test) between patients with AQP4-IgG+ NMOSD and healthy controls. NMOSD = neuromyelitis optica spectrum disorder.